This CE marking notification authorizes Microbix’s REDx STI controls including a Mycoplasma genitalium positive control and an STI negative control — for sale across Belgium and other EU/EEA Member States. Issued via Obelis S.A. under EU Directive 98/79/EC, it enables these NAAT-based quality controls to be used in European clinical and diagnostic laboratories.